SCHEMBL30213397

SCHEMBL30213397

O=C(O)c1cccc(S(=O)(=O)N2CCCCC2)c1

nearest known ligand 0.97

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MAPT P10636 1/20 0.97
IL1RN P18510 1/20 0.97
SMN1; SMN2 Q16637 3/20 0.77
HTT P42858 2/20 0.77
LMNA P02545 2/20 0.77
TSHR P16473 2/20 0.77
GAA P10253 3/20 0.76
NPC1 O15118 1/20 0.76
RAB9A P51151 1/20 0.76
APEX1 P27695 1/20 0.72
ALDH1A1 P00352 5/20 0.69
AKR1C3 P42330 2/20 0.67
AKR1C1 Q04828 1/20 0.67
KDM4E B2RXH2 1/20 0.65
MEN1 O00255 1/20 0.65
KMT2A Q03164 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
THRB P10828 1/20 0.65
NPSR1 Q6W5P4 1/20 0.65

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1001537 1.00 MAPT (0.97) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL4251683 1.00 MAPT (0.97) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL1001486 0.98 MAPT (1.00) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL29463849 0.98 MAPT (1.00) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL3932198 0.95 MAPT (0.94) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL19002726 0.86 SMN1; SMN2 (0.75) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL14507610 0.86 GAA (1.00) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL19002721 0.86 SMN1; SMN2 (0.75) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL17911174 0.86 MAPT (0.78) MAPTIL1RNSMN1; SMN2HTTLMNA
SCHEMBL3824747 0.85 MAPT (0.76) MAPTIL1RNLMNAGAANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119241504-A Spiroindoline inhibitors of KIF18A 沃拉斯查疗法公司 2025-01-03 CN disclosed
WO-2024178255-A1 SOLID FORMULATIONS AND POLYMORPHIC FORMS OF INDOLINE INHIBITORS OF KIF18A VOLASTRA THERAPEUTICS, INC. (US) 2024-08-29 WO disclosed
EP-4392407-A1 SPIRO INDOLINE INHIBITORS OF KIF18A Volastra Therapeutics, Inc. (US) 2024-07-03 EP disclosed
CN-118103352-A Spiroindoline inhibitors of KIF18A 沃拉斯查疗法公司 2024-05-28 CN disclosed
WO-2023028564-A1 SPIRO INDOLINE INHIBITORS OF KIF18A VOLASTRA THERAPEUTICS, INC. (US) 2023-03-02 WO disclosed